Results Snapshot
Figures in Cr
Standalone - Balance Sheet Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Balance Sheet Analysis Highlights
Borrowings
YoY Growth in year ended Mar 2025 is 32.70% vs -37.99% in Mar 2024
Other Long Term Liabilities
YoY Growth in year ended Mar 2025 is 18.18% vs 0.00% in Mar 2024
Fixed Assets
YoY Growth in year ended Mar 2025 is -1.20% vs -1.32% in Mar 2024
Investments
No Investments in the last few periods;
Current Assets
YoY Growth in year ended Mar 2025 is 16.36% vs 5.95% in Mar 2024
Compare Balance Sheet Results of Shukra Pharma.
Figures in Cr
Standalone - Balance Sheet Results
Change(INR)
Change(%)
No of Months
12
12
EQUITY AND LIABILITIES
Share Capital
43.79
14.34
29.45
205.37%
Share Warrants & Outstandings
Total Reserve
19.05
405.26
-386.21
-95.30%
Shareholder's Funds
62.84
422.82
-359.98
-85.14%
Minority Interest
0.00
0.00
0.00
0.00%
Long-Term Borrowings
3.11
7.90
-4.79
-60.63%
Secured Loans
1.64
7.90
-6.26
-79.24%
Unsecured Loans
1.48
0.00
1.48
0.00%
Deferred Tax Assets / Liabilities
3.41
-18.36
21.77
118.57%
Other Long Term Liabilities
0.13
19.98
-19.85
-99.35%
Long Term Trade Payables
0.00
0.00
0.00
0.00%
Long Term Provisions
0.00
10.19
-10.19
-100.00%
Total Non-Current Liabilities
6.65
19.71
-13.06
-66.26%
Current Liabilities
Trade Payables
9.22
63.51
-54.29
-85.48%
Other Current Liabilities
4.27
26.00
-21.73
-83.58%
Short Term Borrowings
1.06
100.99
-99.93
-98.95%
Short Term Provisions
2.74
0.98
1.76
179.59%
Total Current Liabilities
17.28
191.47
-174.19
-90.98%
Total Liabilities
86.77
634.00
-547.23
-86.31%
ASSETS
Non-Current Assets
0.00
0.00
0.00
0.00%
Gross Block
43.42
359.24
-315.82
-87.91%
Less: Accumulated Depreciation
24.03
147.33
-123.30
-83.69%
Less : Impairment of Assets
0.00
0.00
0.00
0.00%
Net Block
19.40
211.91
-192.51
-90.85%
Lease Adjustment
0.00
0.00
0.00
0.00%
Capital Work in Progress
1.95
12.79
-10.84
-84.75%
Intangible assets under development
0.00
0.32
-0.32
-100.00%
Pre-operative Expenses pending
0.00
0.00
0.00
0.00%
Assets in transit
0.00
0.00
0.00
0.00%
Non Current Investments
0.00
14.70
-14.70
-100.00%
Long Term Loans & Advances
0.00
29.47
-29.47
-100.00%
Other Non Current Assets
0.00
0.37
-0.37
-100.00%
Total Non-Current Assets
21.34
274.49
-253.15
-92.23%
Current Assets Loans & Advances
Current Investments
0.00
0.00
0.00
0.00%
Inventories
9.95
130.66
-120.71
-92.38%
Sundry Debtors
8.77
137.21
-128.44
-93.61%
Cash and Bank
12.12
18.02
-5.90
-32.74%
Other Current Assets
20.17
6.40
13.77
215.16%
Short Term Loans and Advances
14.42
67.23
-52.81
-78.55%
Total Current Assets
65.43
359.51
-294.08
-81.80%
Net Current Assets (Including Current Investments)
48.14
168.03
-119.89
-71.35%
Total Current Assets Excluding Current Investments
65.43
359.51
-294.08
-81.80%
Miscellaneous Expenses not written off
0.00
0.00
0.00
0.00%
Total Assets
86.77
634.00
-547.23
-86.31%
Contingent Liabilities
1.40
5.44
-4.04
-74.26%
Total Debt
4.18
108.89
-104.71
-96.16%
Book Value per share (adjusted)
1.44
147.47
-146.03
-99.02%
Annual - Borrowings
Borrowings 4.18 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 32.70% vs -37.99% in Mar 2024
Annual - Other Long Term Liabilities
Other Long Term Liabilities 0.13 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 18.18% vs 0.00% in Mar 2024
Annual - Fixed Assets
Fixed Assets 21.34 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is -1.20% vs -1.32% in Mar 2024
Annual - Investments
Investments 0.00 Cr
in Mar 2025Figures in Cr
No Investments in the last few periods;
Annual - Current Assets
Current Assets 65.43 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 16.36% vs 5.95% in Mar 2024






